Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Female Contraception – Pipeline Review, H1 2018, provides an overview of the Female Contraception (Women’s Health) pipeline landscape.
Contraception (birth control) prevents pregnancy by interfering with the normal process of ovulation, fertilization, and implantation. There are many contraceptive methods which include implants and injections, intrauterine devices (IUDs), pills and vaginal rings, barrier methods, sterilization and natural methods. Contraception generally work by preventing sperm from reaching and fertilizing an egg (barrier and IUD methods), preventing an egg from being released every month (hormones), blocking the reproductive function (sterilization) and preventing a fertilized egg from implanting in the uterus (hormones).
Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Female Contraception – Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Female Contraception (Women’s Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
If you want sample copy of the report feel free to reach us @ https://www.industrydataanalytics.com/request-sample-page.php?gturl=female-contraception-pipeline-review-h1-2018-gmd00052?source=morningoutlook&mode=02
The Female Contraception (Women’s Health) pipeline guide also reviews of key players involved in therapeutic development for Female Contraception and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 4, 5, 3, 8 and 4 respectively. Similarly, the Universities portfolio in Pre-Registration, Phase II and Preclinical stages comprises 1, 1 and 2 molecules, respectively.
Female Contraception (Women’s Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
- Agile Therapeutics Inc
- Bayer AG
- Evofem Biosciences Inc
- Hervana Ltd
- MedinCell SA
- Mithra Pharmaceuticals SA
- Orbis Biosciences Inc
- Teva Pharmaceutical Industries Ltd
- Viramal Ltd
Complete research report is available at https://www.industrydataanalytics.com/female-contraception-pipeline-review-h1-2018-gmd00052-p.php?source=morningoutlook&mode=02
– The pipeline guide provides a snapshot of the global therapeutic landscape of Female Contraception (Women’s Health).
– The pipeline guide reviews pipeline therapeutics for Female Contraception (Women’s Health) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Female Contraception (Women’s Health) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Female Contraception (Women’s Health) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Female Contraception (Women’s Health)
Reasons to buy
- Establish comprehensive understanding of the pipeline activity across this Female Contraception to formulate effective R&D strategies.
- Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage.
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Female Contraception therapeutics.
- Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
IndustryDataAnalytics provides syndicated market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. IndustryDataAnalytics is your single point market research source for all industries including pharmaceutical, chemicals and materials, energy resource, automobile, IT, technology and media, food and beverages, and consumer goods, among others. Contact us for your special interest research needs @
firstname.lastname@example.org And we will get in touch with you within 24hrs and help you find the market research report you need. +1 (704) 266-3234| +91 75070 78687